000300822 001__ 300822
000300822 005__ 20250729103311.0
000300822 0247_ $$2doi$$a10.1038/s41586-025-08973-5
000300822 0247_ $$2pmid$$apmid:40335697
000300822 0247_ $$2ISSN$$a0028-0836
000300822 0247_ $$2ISSN$$a1476-4687
000300822 0247_ $$2altmetric$$aaltmetric:176888235
000300822 037__ $$aDKFZ-2025-00936
000300822 041__ $$aEnglish
000300822 082__ $$a500
000300822 1001_ $$0P:(DE-He78)34b3639de467b2c700920d7cbc3d2110$$aOkonechnikov, Konstantin$$b0$$eFirst author$$udkfz
000300822 245__ $$aOncogene aberrations drive medulloblastoma progression, not initiation.
000300822 260__ $$aLondon [u.a.]$$bNature Publ. Group$$c2025
000300822 3367_ $$2DRIVER$$aarticle
000300822 3367_ $$2DataCite$$aOutput Types/Journal article
000300822 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753777939_3431
000300822 3367_ $$2BibTeX$$aARTICLE
000300822 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300822 3367_ $$00$$2EndNote$$aJournal Article
000300822 500__ $$aDKFZ-ZMBH Alliance / #EA:B062#EA:B430#EA:B086#LA:B430#LA:B062# / 2025 Jun;642(8069):1062-1072
000300822 520__ $$aDespite recent advances in understanding disease biology, treatment of group 3/4 medulloblastoma remains a therapeutic challenge in paediatric neuro-oncology1. Bulk-omics approaches have identified considerable intertumoural heterogeneity in group 3/4 medulloblastoma, including the presence of clear single-gene oncogenic drivers in only a subset of cases, whereas in most cases, large-scale copy number aberrations prevail2,3. However, intratumoural heterogeneity, the role of oncogene aberrations, and broad copy number variation in tumour evolution and treatment resistance remain poorly understood. To dissect this interplay, we used single-cell technologies (single-nucleus RNA sequencing (snRNA-seq), single-nucleus assay for transposase-accessible chromatin with high-throughput sequencing (snATAC-seq) and spatial transcriptomics) on a cohort of group 3/4 medulloblastoma with known alterations in the oncogenes MYC, MYCN and PRDM6. We show that large-scale chromosomal aberrations are early tumour-initiating events, whereas the single-gene oncogenic events arise late and are typically subclonal, but MYC can become clonal upon disease progression to drive further tumour development and therapy resistance. Spatial transcriptomics shows that the subclones are mostly interspersed across tumour tissue, but clear segregation is also present. Using a population genetics model, we estimate medulloblastoma initiation in the cerebellar unipolar brush cell lineage starting from the first gestational trimester. Our findings demonstrate how single-cell technologies can be applied for early detection and diagnosis of this fatal disease.
000300822 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000300822 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300822 7001_ $$0P:(DE-He78)ee036c22158d4b18f5228616af640355$$aJoshi, Piyush Kumar$$b1$$eFirst author$$udkfz
000300822 7001_ $$0P:(DE-He78)467f2d039931bfae1a497c4a6c54804c$$aKörber, Verena$$b2$$eFirst author
000300822 7001_ $$0P:(DE-He78)0a1ab2219242b53553fbdce3aa73e9cf$$aRademacher, Anne$$b3$$udkfz
000300822 7001_ $$0P:(DE-He78)042bf671f0e43607f9c16be966711f16$$aBortolomeazzi, Michele$$b4$$udkfz
000300822 7001_ $$0P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46$$aMallm, Jan-Philipp$$b5$$udkfz
000300822 7001_ $$0P:(DE-He78)67e626330fef4fa3c7eee6a2effaf6b6$$aVaillant, Jan$$b6$$udkfz
000300822 7001_ $$0P:(DE-HGF)0$$ada Silva, Patricia Benites Goncalves$$b7
000300822 7001_ $$0P:(DE-He78)5f5223d7faa01a1e1df8a30d85cff5b0$$aStatz, Britta$$b8
000300822 7001_ $$00000-0003-1733-8385$$aSepp, Mari$$b9
000300822 7001_ $$00000-0002-2242-0562$$aSarropoulos, Ioannis$$b10
000300822 7001_ $$aYamada, Tetsuya$$b11
000300822 7001_ $$0P:(DE-He78)adf0bc22f6c87d09ddb939645a7870ed$$aWittmann, Andrea$$b12$$udkfz
000300822 7001_ $$0P:(DE-He78)2f592d9d8339bee07cca3956b7472b61$$aSchramm, Kathrin$$b13$$udkfz
000300822 7001_ $$0P:(DE-He78)261d2b84aded878003e6e35d18113831$$aBlattner-Johnson, Mirjam$$b14$$udkfz
000300822 7001_ $$0P:(DE-He78)8de7015af76bd61fb0bc13bb3facb1df$$aFiesel, Petra$$b15$$udkfz
000300822 7001_ $$0P:(DE-He78)fae1bf941c5fd76cf5356ecfa1243cc4$$aJones, Barbara$$b16$$udkfz
000300822 7001_ $$0P:(DE-He78)bff9e3e3d86865d2b0836bb8f3ce98f3$$aJäger, Natalie$$b17$$udkfz
000300822 7001_ $$0P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f$$aMilde, Till$$b18$$udkfz
000300822 7001_ $$0P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aPajtler, Kristian$$b19$$udkfz
000300822 7001_ $$0P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271$$avan Tilburg, Cornelis Martinus$$b20$$udkfz
000300822 7001_ $$0P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aWitt, Olaf$$b21$$udkfz
000300822 7001_ $$aBochennek, Konrad$$b22
000300822 7001_ $$0P:(DE-He78)832f5277c0186f22e7704f1930239636$$aWeber, Katharina Johanna$$b23$$udkfz
000300822 7001_ $$aNonnenmacher, Lisa$$b24
000300822 7001_ $$00009-0005-2487-4313$$aReimann, Christian$$b25
000300822 7001_ $$00000-0002-3844-9933$$aGhasemi, David R$$b26
000300822 7001_ $$00000-0002-8731-1121$$aSchüller, Ulrich$$b27
000300822 7001_ $$00000-0003-3302-2719$$aMynarek, Martin$$b28
000300822 7001_ $$aRutkowski, Stefan$$b29
000300822 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b30$$udkfz
000300822 7001_ $$0P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aKorshunov, Andrey$$b31$$udkfz
000300822 7001_ $$0P:(DE-He78)94de5f7413279464b6e738d91dfae1eb$$aRippe, Karsten$$b32$$udkfz
000300822 7001_ $$0P:(DE-He78)91f32735ee876c579d63c05a7f4778dd$$aWestermann, Frank$$b33$$udkfz
000300822 7001_ $$0P:(DE-He78)4584d7a74bed56a23f40eb16ff4d2492$$aThongjuea, Supat$$b34$$udkfz
000300822 7001_ $$0P:(DE-He78)9dbe272aaadbdc810ab0bb291eae428e$$aHöfer, Thomas$$b35$$udkfz
000300822 7001_ $$00000-0001-7563-839X$$aKaessmann, Henrik$$b36
000300822 7001_ $$0P:(DE-He78)a56d7a8e916d458441b5ac9484d73c5d$$aKutscher, Lena$$b37$$eLast author$$udkfz
000300822 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b38$$eLast author$$udkfz
000300822 773__ $$0PERI:(DE-600)1413423-8$$a10.1038/s41586-025-08973-5$$n8069$$p1062-1072$$tNature$$v642$$x0028-0836$$y2025
000300822 909CO $$ooai:inrepo02.dkfz.de:300822$$pVDB
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)34b3639de467b2c700920d7cbc3d2110$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ee036c22158d4b18f5228616af640355$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)467f2d039931bfae1a497c4a6c54804c$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0a1ab2219242b53553fbdce3aa73e9cf$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)042bf671f0e43607f9c16be966711f16$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)67e626330fef4fa3c7eee6a2effaf6b6$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5f5223d7faa01a1e1df8a30d85cff5b0$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)adf0bc22f6c87d09ddb939645a7870ed$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2f592d9d8339bee07cca3956b7472b61$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)261d2b84aded878003e6e35d18113831$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8de7015af76bd61fb0bc13bb3facb1df$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fae1bf941c5fd76cf5356ecfa1243cc4$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bff9e3e3d86865d2b0836bb8f3ce98f3$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271$$aDeutsches Krebsforschungszentrum$$b20$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aDeutsches Krebsforschungszentrum$$b21$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)832f5277c0186f22e7704f1930239636$$aDeutsches Krebsforschungszentrum$$b23$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-3844-9933$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b30$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aDeutsches Krebsforschungszentrum$$b31$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)94de5f7413279464b6e738d91dfae1eb$$aDeutsches Krebsforschungszentrum$$b32$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)91f32735ee876c579d63c05a7f4778dd$$aDeutsches Krebsforschungszentrum$$b33$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4584d7a74bed56a23f40eb16ff4d2492$$aDeutsches Krebsforschungszentrum$$b34$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9dbe272aaadbdc810ab0bb291eae428e$$aDeutsches Krebsforschungszentrum$$b35$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-7563-839X$$aDeutsches Krebsforschungszentrum$$b36$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a56d7a8e916d458441b5ac9484d73c5d$$aDeutsches Krebsforschungszentrum$$b37$$kDKFZ
000300822 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b38$$kDKFZ
000300822 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000300822 9141_ $$y2025
000300822 915__ $$0StatID:(DE-HGF)3003$$2StatID$$aDEAL Nature$$d2025-01-06$$wger
000300822 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1060$$2StatID$$aDBCoverage$$bCurrent Contents - Agriculture, Biology and Environmental Sciences$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1200$$2StatID$$aDBCoverage$$bChemical Reactions$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)1210$$2StatID$$aDBCoverage$$bIndex Chemicus$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNATURE : 2022$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-06
000300822 915__ $$0StatID:(DE-HGF)9960$$2StatID$$aIF >= 60$$bNATURE : 2022$$d2025-01-06
000300822 9202_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000300822 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000300822 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000300822 9201_ $$0I:(DE-He78)B430-20160331$$kB430$$lEntwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen$$x2
000300822 9201_ $$0I:(DE-He78)B086-20160331$$kB086$$lB086 Modellierung Biol. Systeme$$x3
000300822 9201_ $$0I:(DE-He78)B066-20160331$$kB066$$lB066 Chromatin-Netzwerke$$x4
000300822 9201_ $$0I:(DE-He78)W192-20160331$$kW192$$lSingle-cell Open Lab$$x5
000300822 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPädiatrische Gliomforschung$$x6
000300822 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x7
000300822 9201_ $$0I:(DE-He78)B310-20160331$$kB310$$lKKE Pädiatrische Onkologie$$x8
000300822 9201_ $$0I:(DE-He78)FM01-20160331$$kFM01$$lDKTK Koordinierungsstelle Frankfurt$$x9
000300822 9201_ $$0I:(DE-He78)B087-20160331$$kB087$$lB087 Neuroblastom Genomik$$x10
000300822 9200_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000300822 9200_ $$0I:(DE-He78)B430-20160331$$kB430$$lEntwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen$$x1
000300822 9200_ $$0I:(DE-He78)B086-20160331$$kB086$$lB086 Modellierung Biol. Systeme$$x2
000300822 980__ $$ajournal
000300822 980__ $$aVDB
000300822 980__ $$aI:(DE-He78)B062-20160331
000300822 980__ $$aI:(DE-He78)HD01-20160331
000300822 980__ $$aI:(DE-He78)B430-20160331
000300822 980__ $$aI:(DE-He78)B086-20160331
000300822 980__ $$aI:(DE-He78)B066-20160331
000300822 980__ $$aI:(DE-He78)W192-20160331
000300822 980__ $$aI:(DE-He78)B360-20160331
000300822 980__ $$aI:(DE-He78)B300-20160331
000300822 980__ $$aI:(DE-He78)B310-20160331
000300822 980__ $$aI:(DE-He78)FM01-20160331
000300822 980__ $$aI:(DE-He78)B087-20160331
000300822 980__ $$aUNRESTRICTED